Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Companion Animal Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023


 

Available formats:    

StumbleUponEmail

Global Companion Animal Drugs Market:

By Product Type (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Anti-Obesity Drugs, Behavioral Products, Biologic Drugs and Others), By Animal Type (Feline, Canine, and Equine), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

 

Companion Animal Drugs Market Report Description:

 

The Companion Animal Drugs Market report gives a comprehensive outlook on companion animal drugs market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on companion animal drugs market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies companion animal drugs market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the companion animal drugs market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Companion Animal Drugs Market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the companion animal drugs market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of companion animal drug products.

 

Global Companion Animal Drugs Market:

 

Global Companion Animal Drugs Market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of 5.6% over 2017-2023. The market for companion animal drugs projected to reach US$ XX Mn by 2023 owing to rising human and companion animals bondage by means of adoption across the globe.

 

Rising Pet companionship to the human beings expected to drive the companion animal drugs market over the forecast period

 

Companion animals have been trusted for their companionship to the human throughout the history and keeping the companion animals healthy is a top priority for caregivers everywhere in the world, which is expected to drive theCompanion Animal Drugs Market over six years forecast period. Moreover, several studies on human and companion animals’ interactions showed that association with companion animals results in positive health benefits. Therefore, it is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are the primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal drugs over the forecast period.

 

Increasing per pet expenditure in recent times expected to drive market revenue growth

 

Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the caregivers and pet owners to adopt better healthcare services to the companion animals this is projected to drive market revenue growth over the forecast period.

 

North America accounted for larger market revenue share in global companion animal drugs market

 

U.S. market dominated the Companion Animal Drugs Market with largest market share in North America market with moderate growth rate. Europe companion animal drugs market holds a significant share in the global Companion Animal Drugs Market and projected to grow at significant growth over the forecast period.

 

Competition Assessment

 

Key players profiled in the global Companion Animal Drugs Market include:

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Players in the Companion Animal Drugs Market are launching the products in the market to garner larger market share. For instance, in July 2016, Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, received U.S. Food and Drug Administration’s approval for BRAVECTO (fluralaner topical solution) a topical treatment for fleas and ticks for both cats and dogs.

 

Key Findings of the Report:

 

  • Companion Animal Drugs Market expanding at 5.6% CAGR over 2017 to 2023 to reach market value of US$ XX Mn by 2023 owing to increased adoption pet animals and rising zoonotic diseases
  • Based on product type parasiticides accounted for larger market revenue share in 2016 and projected gain larger market revenue share over the forecast period
  • Veterinary clinics distribution channel is the prime source for companion drugs across the globe and expected to remain attractive over the forecast period
  • Players focusing on launching products to retain market position in global companion animal drugs market

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

 

By Product Type

  • Antimicrobials
  • Ectoparasiticides
  • Endoparacitides
  • Endectoparaciticides
  • Anti-inflammatory Drugs
  • Anti-Obesity Drugs
  • Behavioral Products
  • Biologic Drugs
  • Others

 

By Animal Type

  • Feline
  • Canine
  • Equine

 

By Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Others

Distribution Channel

  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Veterinary Clinics
  • E-Commerce

 

Geography

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Venezuela
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • Gulf Cooperation Council (GCC) Countries
    • Israel
    • South Africa
    • Rest of MEA

 

  1. Research Methodology
    • Secondary and Primary research
      • Secondary Sources
      • Primary Sources
    • Market Revenue Estimation Methodology
    • Key Assumptions
    • Acronyms
  2. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  3. Executive summary
  4. Global Companion Animal Drugs Market Dynamics
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  5. Unique Features of the Report
    • Competition analysis
    • Regulatory landscape
    • PESTLE analysis
    • Porter’s analysis
  6. Global Companion Animal Drugs Market Analysis, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Antimicrobials
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Ectoparasiticides
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Endoparacitides
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Endectoparaciticides
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Anti-Inflammatory Drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Anti-Obesity Drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Behavioral Products
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Biologic Drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Analysis, By Animal Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Feline
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Canine
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Equine
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2018 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Topical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2018 – 2024
    • Veterinary Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Veterinary Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Veterinary Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • E-Commerce
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Companion Animal Drugs Market Analysis, By Region, 2013 – 2017 and Forecast, 2018 – 2024
    • North America Companion Animal Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
      • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Antimicrobials
        • Ectoparasiticides
        • Endoparacitides
        • Endectoparaciticides
        • Anti-inflammatory Drugs
        • Anti-Obesity Drugs
        • Behavioral Products
        • Biologic Drugs
        • Others
      • Animal Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Feline
        • Canine
        • Equine
      • Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Veterinary Pharmacies
        • Veterinary Hospitals
        • Veterinary Clinics
        • E-Commerce
      • Route of Administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Oral
        • Parenteral
        • Topical
        • Others
      • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • S
    • Canada
  • Europe Companion Animal Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Drug Therapy
        • Gemcitabine Combination Therapy
        • 5-fluorouracil Combination Therapy
        • Capecitabine Combination Therapy
        • Gemcitabine Alone
      • Radiation Therapy
        • Brachytherapy
        • External Beam Radiation Product (EBRT)
      • Surgery
    • Disease Indication Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
    • Intrahepatic Bile Duct Cancer
    • Extrahepatic Bile Duct Cancer
      • Perihilar Bile Duct Cancer
      • Distal Extrahepatic Bile Duct Cancer
    • Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospitals
      • Pharmacies
      • Oncology Centers
      • Drug Stores
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Germany
    • France
    • K

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553